ReviewInternational journal of hematology2026

Genomic insights transform diagnosis, prognosis, and therapy in BCR::ABL1-negative myeloproliferative neoplasms.

Soji MorishitaPubMed ↗Publisher ↗

No numbers read from the abstract.